{
    "code": "02006199",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02006199",
    "time": "2020-02-25 08:45:21",
    "許可證字號": "衛署藥輸字第006199號",
    "註銷狀態": "已註銷",
    "註銷日期": "82\/08\/12",
    "註銷理由": "檢附資料與規定不符",
    "製造許可登錄編號": "",
    "有效日期": "81\/12\/21",
    "發證日期": "68\/02\/17",
    "許可證種類": "製　劑",
    "舊證字號": "02002505",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200619907",
    "中文品名": "爾達治錠",
    "英文品名": "ALDAZIDE TABLETS",
    "適應症": "心不全症引起之水腫、肝硬變腎炎所引發之水腫或特異性水腫、本態性高血壓",
    "劑型": "110錠劑",
    "包裝": "瓶裝 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BUTHIAZIDE(BUTIZIDETHIABUTAZIDEISOBUTYLHYDROCHO, SPIRONOLACTONE",
    "限制項目": "02輸　入",
    "申請商名稱": "1205501100  凱盛國際股份有限公司",
    "申請商地址": "台北巿長安東路一段２３號７樓之３",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0013000  MERISANT MANUFACTURING AUSTRALIA PTY LTD.",
            "製造廠廠址": "59, LISBON STREET, FAIRFIELD, NEW SOUTH WALES, 2165,AUSTRALIA20 CLARKESTREET CROWS NEST N.S.W. 2065 AUSTRALIA",
            "製造廠公司地址": "20 CLARKESTREET CROWS NEST N.S.W. 2065 AUSTRALIA",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408003500",
            "成分名稱": "BUTHIAZIDE(BUTIZIDETHIABUTAZIDEISOBUTYLHYDROCHO",
            "含量描述": "2.5",
            "含量": "2.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4028001800",
            "成分名稱": "SPIRONOLACTONE",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ]
}